306
Views
10
CrossRef citations to date
0
Altmetric
Research Article

The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan

, , , , , & show all
Pages 1625-1634 | Received 24 May 2013, Accepted 12 Oct 2013, Published online: 04 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Esmeralda C. Teo, Benigno C. Valdez, Jie Ji, Yang Li, Yan Liu, Jonathan E. Brammer, Chitra Hosing, Yago Nieto, Richard E. Champlin & Borje S. Andersson. (2016) Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells. Leukemia & Lymphoma 57:11, pages 2644-2652.
Read now

Articles from other publishers (9)

Benigno C. Valdez, Bin Yuan, David Murray, Jeremy Leon Ramdial, Yago Nieto, Uday Popat, Xiaowen Tang & Borje S. Andersson. (2023) Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells. Frontiers in Oncology 13.
Crossref
Alena Boos, Bernd Martin Gahr, Deung-Dae Park, Verena Braun, Anja Bühler, Wolfgang Rottbauer & Steffen Just. (2023) Hdac1-deficiency affects the cell cycle axis Cdc25-Cdk1 causing impaired G2/M phase progression and reduced cardiomyocyte proliferation in zebrafish. Biochemical and Biophysical Research Communications 665, pages 98-106.
Crossref
Gheath Alatrash, Chantal Saberian, Roland Bassett, Peter F. Thall, Celina Ledesma, Yoshimi Lu, May Daher, Benigno C. Valdez, Jitesh Kawedia, Uday Popat, Rohtesh Mehta, Betul Oran, Yago Nieto, Amanda Olson, Paolo Anderlini, David Marin, Chitra Hosing, Amin M. Alousi, Elizabeth J. Shpall, Gabriela Rondon, Julianne Chen, Muzaffar Qazilbash, Richard E. Champlin & Partow Kebriaei. (2022) Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes. Transplantation and Cellular Therapy 28:8, pages 501.e1-501.e7.
Crossref
Weiling Xie, Weijie Ma, Pan Liu & Fuling Zhou. (2019) Overview of thioredoxin system and targeted therapies for acute leukemia. Mitochondrion 47, pages 38-46.
Crossref
Bin Song, Yan Chen, Yuhong Liu, Chucheng Wan, Longjin Zhang & Wanggang Zhang. (2018) NPAS2 regulates proliferation of acute myeloid leukemia cells via CDC25A ‐mediated cell cycle progression and apoptosis . Journal of Cellular Biochemistry 120:5, pages 8731-8741.
Crossref
Ling Wang, Raynier Devillier, Ming Wan, Justine Decroocq, Liang Tian, Sabine Fürst, Li-Ning Wang, Norbert Vey, Xing Fan, Didier Blaise & Jiong Hu. (2018) Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes. Bone Marrow Transplantation 54:3, pages 458-464.
Crossref
Benigno C. Valdez, Yang Li, David Murray, Yan Liu, Yago Nieto, Richard E. Champlin & Borje S. Andersson. (2017) Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells. Oncotarget 9:3, pages 3908-3921.
Crossref
Annette Brenner, Håkon Reikvam, Antonio Lavecchia & Øystein Bruserud. (2014) Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms. Molecules 19:11, pages 18414-18447.
Crossref
Guiyun Song, Benigno C. Valdez, Yang Li, Yan Liu, Richard E. Champlin & Borje S. Andersson. (2014) Synergistic Cytotoxicity of Sorafenib with Busulfan and Nucleoside Analogs in Human FMS-like Tyrosine Kinase 3 Internal Tandem Duplications–Positive Acute Myeloid Leukemia Cells. Biology of Blood and Marrow Transplantation 20:11, pages 1687-1695.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.